Evidence map›Paper›PMID 36916924›Full record

ArticleJournal of virology2023

Strain-Dependent Restriction of Human Cytomegalovirus by Zinc Finger Antiviral Proteins.

Maria Jose Lista, Adam A Witney, Jenna Nichols, Andrew J Davison, Harry Wilson, Katie A Latham, Benjamin J Ravenhill, Katie Nightingale, Richard J Stanton, Michael P Weekes and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Maria Jose Lista *Department of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
Adam A Witney *Institute of Infection & Immunity, St George's, University of London, London, United Kingdom.
Jenna NicholsMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Andrew J DavisonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0002-4991-9128
Harry WilsonDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-3185-1073
Katie A LathamInstitute of Infection & Immunity, St George's, University of London, London, United Kingdom.
Benjamin J RavenhillCambridge Institute for Medical Research, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Katie NightingaleCambridge Institute for Medical Research, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Richard J StantonDivision of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
Michael P WeekesCambridge Institute for Medical Research, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Stuart J D NeilDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0003-3306-5831
Chad M SwansonDepartment of Infectious Diseases, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.ORCID 0000-0002-6650-3634
Blair L StrangInstitute of Infection & Immunity, St George's, University of London, London, United Kingdom.ORCID 0000-0001-9407-1974
King's College London · GBSt George's, University of London · GBUniversity of Cambridge · GBMRC University of Glasgow Centre for Virus Research · GBCardiff University · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Cellular antiviral factors that recognize viral nucleic acid can inhibit virus replication. These include the zinc finger antiviral protein (ZAP), which recognizes high CpG dinucleotide content in viral RNA. Here, we investigated the ability of ZAP to inhibit the replication of human cytomegalovirus (HCMV). Depletion of ZAP or its cofactor KHNYN increased the titer of the high-passage HCMV strain AD169 but had little effect on the titer of the low-passage strain Merlin. We found no obvious difference in expression of several viral proteins between AD169 and Merlin in ZAP knockdown cells, but observed a larger increase in infectious virus in AD169 compared to Merlin in the absence of ZAP, suggesting that ZAP inhibited events late in AD169 replication. In addition, there was no clear difference in the CpG abundance of AD169 and Merlin RNAs, indicating that genomic content of the two virus strains was unlikely to be responsible for differences in their sensitivity to ZAP. Instead, we observed less ZAP expression in Merlin-infected cells late in replication compared to AD169-infected cells, which may be related to different abilities of the two virus strains to regulate interferon signaling. Therefore, there are strain-dependent differences in the sensitivity of HCMV to ZAP, and the ability of low-passage HCMV strain Merlin to evade inhibition by ZAP is likely related to its ability to regulate interferon signaling, not the CpG content of RNAs produced from its genome.

Indexed as

CytomegalovirusInterferon Type IAntiviral AgentsHumansNeurofibromin 2RNA-Binding ProteinsVirus ReplicationZinc FingersAntiviral AgentsInterferon Type INeurofibromin 2RNA-Binding Proteinscytomegalovirusherpesvirusesinterferonszinc finger antiviral protein

Identifiers

PMID36916924
PMCPMC10062169
OpenAlexW4324128956

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.